Non-classical HLA-G antigen and its role in the cancer progression

Cancer Investigation
Piyush Tripathi, Suraksha Agrawal

Abstract

Various changes take place during the progression of cancer, some of which are favorable for tumor development and may help to escape the immunosurvillance. These include changes in the microenvironment around the developing tumor, which could be produced in response to phenotypic alterations or could modulate the expression of certain markers of tumor development. One such newly discovered molecule is HLA-G, which has been found to have immunosuppressive and immunomodulatory roles in the cancer development. The regulatory sequences, as seen, may be induced by various factors that may be present in tumor microenvironment. A recent study has investigated the antigen -G as a marker of susceptibility to chemotherapy. Further, its expression on tumors and how it can be exploited for diagnosis and therapy is discussed in this article.

References

May 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·A Ishitani, D E Geraghty
Jul 1, 1990·Immunology Today·H G Ljunggren, K Kärre
Feb 15, 1995·Journal of the National Cancer Institute·M G SandaJ W Simons
Jan 1, 1994·Annual Review of Immunology·T BoonA Van Pel
Jan 1, 1996·British Journal of Cancer·P KorkolopoulouK C Gatter
Aug 1, 1995·Biochemical Society Transactions·B Van den EyndeT Boon
Jan 1, 1995·Advances in Cancer Research·F GarridoF Ruiz-Cabello
Mar 1, 1997·Immunology Today·G Girolomoni, P Ricciardi-Castagnoli
May 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·P PaulE D Carosella
Jun 24, 1998·The Journal of Clinical Investigation·D J HicklinS Ferrone
Apr 6, 1999·The Journal of Experimental Medicine·S Rajagopalan, E O Long
Jun 18, 1999·Transplantation Proceedings·S MaierE H Weiss
Sep 9, 1999·Journal of Reproductive Immunology·M KirszenbaumE D Carosella
Sep 9, 1999·Journal of Reproductive Immunology·F Adrián CabestréP Paul
Jun 8, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·S FournelP Le Bouteiller
Sep 21, 2000·Journal of Reproductive Immunology·D R BainbridgeI L Sargent
Jan 4, 2001·Human Immunology·S J Gobin, P J van den Elsen
Feb 7, 2001·International Immunology·B RiteauN Rouas-Freiss
Feb 28, 2001·Immunology Today·E D CarosellaN Rouas-Freiss
Sep 22, 2001·Science·M GirardiA C Hayday
Oct 10, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·Y M VyasB Dupont
Nov 8, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·P ForteJ D Seebach
Jan 5, 2002·Journal of Virology·Juliet V SpencerThomas J Schall
Feb 6, 2002·The Journal of Experimental Medicine·Franca GerosaGiorgio Trinchieri
Apr 3, 2002·Trends in Molecular Medicine·Robert Brown, Gordon Strathdee

❮ Previous
Next ❯

Citations

Nov 26, 2010·Cellular and Molecular Life Sciences : CMLS·Eduardo A DonadiPhilippe Moreau
Apr 23, 2011·Cancer Biotherapy & Radiopharmaceuticals·Robert L ElliottJonathan F Head
May 4, 2007·The Journal of Clinical Investigation·Jeremy B Swann, Mark J Smyth
Jan 12, 2011·Annual Review of Immunology·Matthew D VeselyMark J Smyth
Dec 22, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Roy M BremnesLill-Tove Busund
Aug 21, 2007·Seminars in Cancer Biology·Barbara Seliger, Gerald Schlaf
May 9, 2007·Journal of Reproductive Immunology·Noriko SageshimaAkiko Ishitani
Jun 18, 2009·Tissue Antigens·B-L LiW-H Yan
May 11, 2007·Xenotransplantation·Mark D Crew
May 23, 2008·Journal of Cellular and Molecular Medicine·W-H YanB-L Li
Apr 15, 2011·Immunological Reviews·Sergio A QuezadaJames P Allison
Aug 23, 2011·International Journal of Cancer. Journal International Du Cancer·Aifen LinWei-Hua Yan
Oct 6, 2009·Journal of Cellular and Molecular Medicine·A LinW-H Yan
Sep 4, 2009·International Journal of Cancer. Journal International Du Cancer·Claudia B M BijenHans W Nijman
Aug 19, 2015·Frontiers in Oncology·Malgorzata WachowskaJakub Golab
Oct 22, 2008·Thérapie·Inès Zidi, Aghleb Bartegi
Feb 2, 2018·Immunological Investigations·Gehan Abd-Elfatah Tawfeek, Suzan Alhassanin
Sep 19, 2009·Expert Review of Anticancer Therapy·Ana Paula de Souza, Cristina Bonorino
Nov 19, 2010·Expert Review of Hematology·Wei-Hua Yan
May 16, 2007·Médecine sciences : M/S·Alexandre IannelloAli Ahmad
Jul 10, 2019·Journal of Translational Medicine·Meysam Moghbeli
Dec 5, 2019·Journal of Clinical Pathology·Sony KadiamJayalakshmi Mariakuttikan
Sep 1, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·Mehdi HaghiAbbas Sahebghadam Lotfi
Aug 31, 2016·International Journal of Oncology·Jinbao SunXue Zhang
Dec 6, 2018·Journal for Immunotherapy of Cancer·Junaid RajaHyun S Kim
Feb 5, 2008·Cancer Research·Mirjana Urosevic, Reinhard Dummer
Apr 4, 2021·Archives of Dermatological Research·Andrezza Telles WestinCacilda Da Silva Souza
May 24, 2008·Molecular Cancer·Laura MenendezJohn F McDonald

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.